E. Karataylı Et Al. , "Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil," HEPATOLOGY , vol.46, no.4, Utah, United States Of America, pp.662, 2007
Karataylı, E. Et Al. 2007. Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil. HEPATOLOGY , (Utah, United States Of America), 662.
Karataylı, E., Karayalçın, S., Karaaslan, H., Kayhan, H., Türkyılmaz, A. R., Şahin, F., ... Yurdaydın, C.(2007). Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil . HEPATOLOGY (pp.662). Utah, United States Of America
Karataylı, Ersin Et Al. "Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil," HEPATOLOGY, Utah, United States Of America, 2007
Karataylı, Ersin Et Al. "Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil." HEPATOLOGY , Utah, United States Of America, pp.662, 2007
Karataylı, E. Et Al. (2007) . "Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil." HEPATOLOGY , Utah, United States Of America, p.662.
@conferencepaper{conferencepaper, author={Ersin Karataylı Et Al. }, title={Drug susceptibility testing of a novel mutation pattern (A181S M204I) conferring resistance to lamivudine and adefovir dipivoxil}, congress name={HEPATOLOGY}, city={Utah}, country={United States Of America}, year={2007}, pages={662} }